Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 802 results for "iibs"

Setting targets for river water quality
New Straits Times

Setting targets for river water quality

River catchments in Malaysia are in dire straits. The recent contamination that led to the closure of the Sungai Semenyih water treatment plant only reinforces the need for more effective watershed management mechanisms and pollution control. New Straits Times, 4 minutes ago

91 images for iibs

Concrete Products, 10 hours ago
EuroInvestor, 14 hours ago
EuroInvestor, 14 hours ago, 14 hours ago
PharmaVOICE, 2 weeks ago
Invest In Brussels, 1 week ago
BioSpace, 6 days ago
Nasdaq, 1 week ago, 2 weeks ago
Pharmaceutical, 2 weeks ago

MINERVA NEUROSCIENCES ANNOUNCES POSITIVE DATA FROM SIX-MONTH EXTENSION OF PHASE IIB TRIAL OF MIN-101 MONOTHERAPY IN SCHIZOPHRENIA : Data show continuous improvement in negative symptoms, stable positive symptoms and extended safety profile

WALTHAM, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced data ...
 4 Traders14 hours ago BRIEF-Minerva Neurosciences announces positive data from six-month extension of phase IIB trial of min-101 monotherapy in schizophrenia  Reuters UK14 hours ago MINERVA NEUROSCIENCES ANNOUNCES ACCEPTANCE OF PRESENTATIONS OF CLINICAL DATA WITH MIN-101 AND MIN-117 AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING : MIN-101 to be highlighted in oral presentation  4 Traders1 week ago Minerva Neurosciences : Announces Acceptance of Presentations of Clinical Data With MIN-101 and MIN-117 at American College of Neuropsychopharmacology Annual Meeting  4 Traders1 week ago

GSK drops a pair of late-stage candidates in COPD, HIV

GlaxoSmithKline ($GSK) had hoped to have the first oral maturation inhibitor to treat HIV. But now it may be off-track on that goal. It has discontinued its lead, Phase IIb maturation inhibitor BMS-955176, which GSK acquired from Bristol-Myers ...
 FierceBiotech7 hours ago

Auven to Sell Subsidiary, Dry Eye Disease Candidate to Sun Pharma

Auven Therapeutics said today it will sell its Ocular Technologies subsidiary—whose key asset is the Phase III dry eye disease treatment candidate Seciera TM (OTX-101)—to Sun Pharma for $40 million upfront, plus undisclosed milestone payments ...
 Genetic Engineering News7 hours ago

The First Peanut Allergy Therapy Might Soon Hit The Shelves, DBV Tech Reveals

DBV Technologies announced outstanding Phase IIb results for Viaskin Peanut, which could be the first-ever commercial peanut allergy therapy in the near future. However, competition is stiff. DBV Technologies, the first French Biotech to enter the ...
 BioSpace9 hours ago DBV peanut allergy drug maintains response rates, compliance in 2-year follow-up trial  FierceBiotech1 day ago Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut days ago DBV Tech Release: Topline Results From Two-Year Follow-Up Study Of Viaskin Peanut Show Long-Lasting And High Levels Of Desensitization To Peanut  BioSpace1 day ago

BRIEF-Minerva Neurosciences posts positive data on schizophrenia drug

n"Oct 26 Minerva Neurosciences Inc * Minerva neurosciences announces positive data from six-month extension of phase iib trial of min-101 monotherapy in schizophrenia * Minerva neurosciences -min-101 was reported to be well tolerated at both doses ...
 Reuters UK13 hours ago Minerva Neurosciences posts positive data on schizophrenia drug  Reuters UK10 hours ago

Parker Zone 1 and Zone 2 ATEX Explosion proof servo motors available from Micromech.

EX any EY motors are available in 70mm- 155 mm frame sizes. Zone 1 EX Range Parker EX series motors feature an explosion-proof housing, designed for use in zone 1 explosive atmospheres. Two versions are available conforming with either North ...
 Converter News11 hours ago

Can Prothena (PRTA) Pull a Surprise This Earnings Season?

Prothena Corporation plc PRTA is scheduled to report third-quarter 2016 results on Nov 1 after the market closes. Last reported quarter, the company recorded a negative earnings surprise of 32.58%. Let's see how things are shaping up for this ...
 Yahoo! Singapore12 hours ago

Verona secures cash for midphase cystic fibrosis trial

Verona Pharma (LON:VRP) has secured funding for a Phase IIa trial of its PDE3/PDE4 inhibitor RPL554 in cystic fibrosis patients. The funding, which comes four months after Verona raised £45 million ($55 million), was provided by the Cystic Fibrosis ...
 FierceBiotech12 hours ago
Art of Jewellery

IBJA to organize 4th edition of India International Bullion Summit on 19th December

26-10-201618:10PM AOJ E-NEWS: The India Bullion and Jewellers Association Ltd (IBJA) is gearing up for the 4th edition of its annual bullion conclave the India International Bullion Summit. The summit will be held at Hotel Sahara Star, ...
 Art of Jewellery13 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less